STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD

• Główni autorzy: O. A. Radaeva (Autor), L. A. Balykova (Autor), K. Ya. Zaslavskaya (Autor), A. V. Taganov (Autor), P. A. Bely (Autor), Yu. A. Kostina (Autor), E. V. Negodnova (Autor), S. V. Mashnina (Autor), D. D. Bessheinov (Autor), M. S. Iskandyarova (Autor), V. V. Eremeev (Autor), N. M. Chumakov (Autor)
• Format: Książka
• Wydane: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2022-05-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

The article presents modern scientific data on long-term clinical and pathogenetic effects of the antiviral drug Areplivir (Favipiravir) in patients with metabolic syndrome in the post-COVID period.The aim of the article is to study long-term cytokine-mediated (IL-6/sIL6r and LIF/sLIFr) pathogenetic...